FindTrial
Sign In

to compare effect of different doses of oxytocin in caesarean secton.

A Randomized double blind trial of bolus doses of oxytocin in Elective Caesarean Section.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018249
Enrollment
90
Registered
2019-03-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Group 2: Group 2 patients will receive 2 unit of oxytocin IV bolus after cord clamp following Caesarean delivery. Intervention2: Group 3: Group 3 patients will receive 3 unit of Oxytoci

Sponsors

PONDICHERRY INSTITUTE OF MEDICAL SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ninety females between the gestational age of 36 to 41, singleton pregnancy, ASA category 1 or 2, for elective caesarean delivery under spinal anesthesia, first time or second time lower segment caesarean section

Exclusion criteria

Exclusion criteria: Known allergy to oxytocin Pregnancy induced hypertension Eclampsia Abnormal placentation o Uterine fibroids Coagulation disorders Severe anemia /thrombocytopenia, Two or more previous caesarean section.

Design outcomes

Primary

MeasureTime frame
Level of adequacy in uterine contractionsTimepoint: 2 MINUTES AFTER ADMINISTRATION OF STUDY DOSE—

Secondary

MeasureTime frame
Blood lossTimepoint: Postoperative period;Hemodynamic parametersTimepoint: Intraoperative period;Side effects of OxytocinTimepoint: Intraoperative period—

Countries

India

Contacts

Public ContactJoe Joseph

Pondicherry Institute of Medical Sciences

koshysm@yahoo.com09443287707

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026